Skip to content

Exploring the Effect of Aromatherapy

Exploring the Effect of Aromatherapy Inhalation for Managing Pain, Anxiety, and Nausea/Vomiting Throughout the Laboring Process

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07155876
Enrollment
128
Registered
2025-09-04
Start date
2025-10-15
Completion date
2026-09-01
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Labor Pain, Nausea and Vomiting

Brief summary

To explore the effect of aromatherapy in laboring patients with pain, anxiety, and/or nausea/vomiting.

Interventions

OTHERAromatherapy plus standard of care

The participant is offered an aromatherapy scented tab that is attached to their gown based on symptoms (anxiety, pain, and/or nausea/vomiting): 1. Pain or anxiety: lavender or lavender sandalwood, 2. Nausea/vomiting: orange ginger, or 3. Despite the type of discomfort, the participant may request the alternate scent if the scent offered is not to their liking. Plus, the patient receives SoC for treatment based on symptoms (anxiety, pain, and/or nausea/vomiting) as prescribed by the physician.

Participant receives symptom management medications for pain, nausea/vomiting, and/or anxiety as prescribed by the physician.

Sponsors

Baptist Health South Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Pregnant patients at least 18 years old in spontaneous labor or induction of labor (despite transitioning into a caesarean section)

Exclusion criteria

* Patients who are unable to detect scents/odors * Patients with known allergies to aromatherapy and/or its components

Design outcomes

Primary

MeasureTime frameDescription
Relief of nausea/vomitingMeasured before and after receiving standard of care (SoC) or Intervention+SoC.Measured in the control and intervention groups before and after receiving treatment (yes or no - presence of nausea/vomiting).
Decreased anxietyMeasured before and after receiving standard of care (SoC) or Intervention+SoC.Measured before and after receiving treatment in both the control and intervention groups. Anxiety level = 0 =none, 1 = minimal (a little), 2 = moderate (medium), and 3 = severe (a lot).
Pain relief (scale of 0 to 10)Measured before and after receiving standard of care (SoC) or Intervention+SoC.Level of pain is measured before and after receiving treatment in both the control and interventions groups. Pain is measured on a scale of 0 to 10 (0 = no pain, 10 = severe pain).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026